BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32057213)

  • 1. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study.
    Kakkos SK; Arnaoutoglou E; Tsolakis IA; Giannoukas A; Papadimitriou CA; Kentepozidis N; Boukovinas I; Kalofonos HP; Labropoulos N; Matsagkas M
    Int Angiol; 2020 Apr; 39(2):112-117. PubMed ID: 32057213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
    Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
    Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.
    Mandalà M; Barni S; Prins M; Labianca R; Tondini C; Russo L; Milesi A; Cremonesi M; Zaccanelli M; Regonesi C; Moro C; Falanga A
    Ann Oncol; 2010 Apr; 21(4):871-876. PubMed ID: 19713246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.
    Kenmotsu H; Notsu A; Mori K; Omori S; Tsushima T; Satake Y; Miki Y; Abe M; Ogiku M; Nakamura T; Takagi M; Ochiai H; Yasui H; Takahashi T
    Cancer Med; 2021 Feb; 10(3):895-904. PubMed ID: 33421344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
    Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
    Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
    Pant A; Liu D; Schink J; Lurain J
    Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis.
    Di Nisio M; Candeloro M; Rutjes AWS; Porreca E
    J Thromb Haemost; 2018 Jul; 16(7):1336-1346. PubMed ID: 29754426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
    Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.
    Lyman GH; Eckert L; Wang Y; Wang H; Cohen A
    Oncologist; 2013; 18(12):1321-9. PubMed ID: 24212499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, clinical pattern and outcome of thrombosis in cancer patients in Saudi Arabia.
    Aleem A; Al Diab AR; Alsaleh K; Algahtani F; Alsaeed E; Iqbal Z; El-Sherkawy MS
    Asian Pac J Cancer Prev; 2012; 13(4):1311-5. PubMed ID: 22799324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy.
    Kamiya M; Kawahara S; Kamioka Y; Murakawa M; Aoyama T; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Masuda M; Morinaga S
    Anticancer Res; 2023 Apr; 43(4):1741-1747. PubMed ID: 36974795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
    Riedl JM; Posch F; Bezan A; Szkandera J; Smolle MA; Winder T; Rossmann CH; Schaberl-Moser R; Pichler M; Stotz M; Stöger H; Gerger A
    BMC Cancer; 2017 Jun; 17(1):415. PubMed ID: 28619086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.